<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163232">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02046096</url>
  </required_header>
  <id_info>
    <org_study_id>12-018</org_study_id>
    <nct_id>NCT02046096</nct_id>
  </id_info>
  <brief_title>Cook IVC Filter Study</brief_title>
  <acronym>CIVC</acronym>
  <official_title>Cook IVC Filter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, multicenter, single-arm clinical study will further evaluate the safety
      and effectiveness of Cook's permanent and retrievable inferior vena cava (IVC) filters
      (specifically, the Günther Tulip® Vena Cava Filter and Cook Celect® Vena Cava Filters) in
      patients in need of temporary or permanent IVC filter placement for the prevention of
      pulmonary embolism.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Technical placement success and freedom from new symptomatic PE while a filter is indwelling.</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from major adverse events.</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">470</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All subjects enrolled will receive an IVC filter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Günther Tulip® Vena Cava Filter and Cook Celect® Vena Cava Filters</intervention_name>
    <description>Temporary or permanent filter placement for the prevention of pulmonary embolism</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Requires temporary or permanent IVC filter placement for the prevention of PE

        Exclusion Criteria:

          -  Less than 18 years of age

          -  Allergy or sensitivity to device materials or contrast medium

          -  Pregnant or planning to become pregnant in the next 12 months

          -  Patient refuses blood transfusions

          -  At risk of septic embolism

          -  Life expectancy less than 12 months

          -  Existing IVC filter

          -  Duplicate IVC

          -  Anatomy that would prevent safe filter placement (e.g., condition of access vessels)

          -  IVC diameter &gt; 30 mm or &lt; 15 mm
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>H. Bob Smouse, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OSF St. Francis/Peoria Radiology Research and Education Foundation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Feezor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida Health-Shands</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dion Bates, MS</last_name>
    <phone>765-463-7537</phone>
    <email>dbates@medinst.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Florida Health - Shands</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>OSF St. Francis/Peoria Radiology Research and Education Foundation</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stony Brook Medicine</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>January 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Venous thrombosis</keyword>
  <keyword>pulmonary embolism</keyword>
  <keyword>vena cava, inferior</keyword>
  <keyword>vena cava filters</keyword>
  <keyword>venous thromboembolism</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
